OCT 13, 2020 2:30 PM SGT

Panel Discussion: Cancer Care in different regions and what are the current standard of care in Lung cancer

Speakers
  • Senior Consultant Pulmonology, Critical Care, Allergy and Sleep Medicine
    Biography

      Dr. Arjun Khanna is a Pulmonologist and intensivist based at Delhi NCR. He is amongst the few DM Pulmonary and Critical care medicine in the country. He is a fellow of the American college of Chest Physicians and a Diplomate of the European board, in adult respiratory diseases. He has been awarded as the Global rising star in Pulmonary Medicine by the Lung health council in 2019.



      His areas of interest include, Difficult to control airways diseases, Interstitial lung diseases, Sleep medicine, Community health and Infections of the respiratory system. I have more than 50 peer reviewed publications, book chapters and abstracts in national and international journals.

    • Clinical Associate Professor - Honorary Consultant, Department of Medicine, Queen Mary Hospital - Honorary Consultant, Department of Medicine, HKU-Shenzhen Hospital
      Biography

        MBBS (HK), BSc(BiomedSc) (HK), MD (HK), PhD (HK), MRCP (UK), FHKCP, FHKAM (Medicine), FRCP (Edin, Glasg & Lond) 



        Dr David CL Lam is a respiratory physician with interest in translational research and clinical trials in respiratory diseases including lung cancer, smoking and airway physiology, COPD and interventional pulmonology. His research focuses on translational research with biomarkers in lung cancer and airway.



        In his research laboratory, new lung cancer and immortalized normal bronchial epithelial cell lines representing local Chinese population are established and characterized, and they are being used as cellular models for translational research on lung cancer, smoking and airway physiology research. Plasma EGFR mutations and circulating tumor markers are studied.



        He also performs bronchoscopy including endobronchial ultrasonography and autofluorescence imaging. He acts as Co-convenor in the Special Interest Group in Interventional Pulmonology and the Hong Kong Pleural Disease Network under the Hong Kong Thoracic Society. He is currently in the International Lung Screening Trial (ILST) Consortium, steering lung screening and relevant biomaker research.

      • Chair of Department of Pathology, Chi Mei Medical Center
        Biography
          Dr Li is the Chair of Department of Pathology, Chi Mei Medical Center, and he also serves as a professor at Southern Taiwan University of Science and Technology, as well as a joint-appointment associate investigator at National Institute of Cancer Research (Taiwan). He got his Medical Degree from Kaohsiung Medical University in 2002. In 2012, he got his Doctor of Philosophy in biomedical sciences from National Sun Yat-sen University. As a physician scientist, his current research interest is integrative analysis of genetic, epigenetic, and expression alternations during cancer progression and metastasis, with special emphasize on sarcomas and therapy-resistant cancers. With the opportunities to integrate large-scaled clinical samples and advanced functional evaluations, he has been more focused on potential therapeutic opportunities of oncogenic metabolic transformations and the mechanisms how the metabolic characters of cancer implicate tumor progression.
        • Senior Consultant, Associate Professor - Medical Oncology, Sing Health Research, Singapore
          Biography

            Assoc Prof Darren Lim is a Senior Consultant, Division of Medical Oncology, National Cancer Centre Singapore (NCCS) and the Assoc Prof, Duke-NUS Medical School. In 2012, A/Prof Lim was awarded the Clinician Scientists Award (CSA). His research interests in oncology are in early phase clinical trials with biological correlates head, neck and lung cancer. He is also actively involved in the development of biomarker correlative clinical trials.



            Research Interest:



            Development of preclinical/clinical studies of novel drug combinations in endemic cancers, Provision of pharmaco-kinetic and -genomic support to early phase clinical studies.


          Show Resources
          You May Also Like
          SEP 10, 2020 9:00 AM PDT
          C.E. CREDITS
          SEP 10, 2020 9:00 AM PDT
          Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
          SEP 03, 2020 9:00 AM PDT
          C.E. CREDITS
          SEP 03, 2020 9:00 AM PDT
          DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
          C.E. CREDITS
          This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
          JUN 17, 2020 1:30 PM PDT
          C.E. CREDITS
          JUN 17, 2020 1:30 PM PDT
          Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
          NOV 05, 2020 7:00 AM PST
          C.E. CREDITS
          NOV 05, 2020 7:00 AM PST
          DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
          NOV 19, 2020 8:00 AM GMT
          C.E. CREDITS
          NOV 19, 2020 8:00 AM GMT
          Date: November 19, 2020 Time: 12:00am (PDT), 9:00am (CET), 4:00pm (SGT) We present split-FISH, a multiplexed fluorescence in situ hybridization method that leverages a split-probe design to...
          Loading Comments...
          Show Resources